John G. Ullman & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$10.1M |
| 2 |
AT&T
T
|
+$9.79M |
| 3 |
ExxonMobil
XOM
|
+$5.52M |
| 4 |
CACI
CACI
|
+$4.78M |
| 5 |
Dominion Energy
D
|
+$3.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$1.78M |
| 2 |
Abbott
ABT
|
+$1.67M |
| 3 |
Azenta
AZTA
|
+$1.06M |
| 4 |
Lumentum
LITE
|
+$601K |
| 5 |
Microsoft
MSFT
|
+$514K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.44% |
| 2 | Technology | 24.17% |
| 3 | Industrials | 19.52% |
| 4 | Utilities | 8.63% |
| 5 | Communication Services | 6.63% |
Similar funds
John G. Ullman & Associates's Q3 2020 Portfolio in Review
As of Q3 2020, John G. Ullman & Associates held 132 positions worth $483M, up 18% from $410M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
John G. Ullman & Associates deployed $54.1M of net new capital in Q3 2020, opening 23 new positions and adding to 33 existing holdings. Its largest new stake was CACI: 22,100 shares worth $4.71M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 36% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $1.78M trimmed.
- John G. Ullman & Associates's largest Q3 2020 buy was CACI: 22,100 shares worth $4.71M.
- John G. Ullman & Associates added most to Cisco in Q3 2020, an estimated $10.1M increase.
- John G. Ullman & Associates's biggest Q3 2020 reduction was Thermo Fisher Scientific, cutting an estimated $1.78M.
- John G. Ullman & Associates fully exited Schwab US Large-Cap Growth ETF in Q3 2020, selling an estimated $227K.
- John G. Ullman & Associates's ten largest holdings make up 37% of its $483M portfolio in Q3 2020.
- John G. Ullman & Associates opened 23 new positions and closed 4 in Q3 2020.
- John G. Ullman & Associates's portfolio value rose 18% quarter-over-quarter to $483M.
Based on John G. Ullman & Associates's 13F filing for Q3 2020, filed 6 Nov 2020.